Answers are grounded in this paper and cite their sources.
reports on bronchodilator infusions which were given as initial therapy for acute asthma and for short periods only, where it would be a simple matter to change treatment for those who failed to respond.We cannot really contest his views on the ethical committee, which may apply criteria more stringent than elsewhere.The information presented in our paper suggested that a salbutamol infusion of 10 g/min is no more effective than the amino- phylline infusion, and Professor Grant may well be correct to state, as we inferred, that with adequate administration of nebulised bronchodilator drugs an intravenous infusion may not make a significant contribution to airway function.The analysis for significant differences in lung function between the two infusion groups included all the patients up to the time of withdrawal from the study if before 36 h.Dr Anderson assumes incorrectly that the data on those patients withdrawn before 36 h were not included in these analyses.The fact that of the six patients withdrawn from the salbutamol group before 36 h, two were responding faster than the group as a whole makes the response between the two groups less marked than Dr Anderson suggests.
No takes yet. Share an insight, caveat, or question.
M. N. G. Dukes (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: